Immuneering Corp. (IMRX)
6.16
-0.08
(-1.28%)
USD |
NASDAQ |
Dec 10, 16:00
6.12
-0.04
(-0.65%)
After-Hours: 20:00
Immuneering EPS Diluted (Quarterly): -0.3772 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Fortress Biotech, Inc. | 0.111 |
| BridgeBio Pharma, Inc. | -0.9525 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -14.96M |
| Total Expenses (Quarterly) | 14.96M |
| Enterprise Value | 174.10M |
| Earnings Yield | -28.95% |
| Normalized Earnings Yield | -28.95 |